Novel murine models of ARID1A and PBRM1-deficient cholangiocarcinoma for preclinical discovery and development

被引：0
|
作者：
Conboy, Caitlin B.
Tomlinson, Jennifer L.
Watkins, Ryan D.
Millender, Jayla T.
Carlson, Danielle M.
Smoot, Rory L.
Robertson, Keith D.
Gores, Greg J.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-A048
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Abstract A
引用
收藏
页数：2
相关论文
共 50 条
  • [41] High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study
    Bi, Chao
    Liu, Mei
    Rong, Weiqi
    Wu, Fan
    Zhang, Yang
    Lin, Shengtao
    Liu, Yunhe
    Wu, Jianxiong
    Wang, Liming
    BMC CANCER, 2019, 19 (1)
  • [42] High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study
    Chao Bi
    Mei Liu
    Weiqi Rong
    Fan Wu
    Yang Zhang
    Shengtao Lin
    Yunhe Liu
    Jianxiong Wu
    Liming Wang
    BMC Cancer, 19
  • [43] PBRM1-deficient PBAF complexes target de novo genomic loci to activate NF-κB pathway in clear cell renal cell carcinoma
    Yao, Xiaosai
    Hong, Jing Han
    Nargund, Amrita
    Ng, Michelle Shu Wen
    Heng, Hong Lee
    Li, Zhimei
    Guan, Peiyong
    Sugiura, Masahiro
    Chu, Pek Lim
    Wang, Loo Chien
    Ye, Xiaofen
    Yauch, Robert
    Chang, Kenneth Tou-En
    Sobota, Radoslaw M.
    Tan, Patrick
    Teh, Bin Tean
    CANCER RESEARCH, 2023, 83 (07)
  • [44] Beta-catenin-dependent erythropoiesis in adult mice deficient in hepatic ARID1A chromatin remodeler
    Riou, R.
    Ladli, M.
    Gougelet, A.
    Cecile, G.
    Wang, Z.
    Verdier, F.
    Colnot, S.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S47 - S47
  • [45] Novel therapeutic targets for ARID1A mutant ovarian clear cell carcinoma (OCCC)
    Miller, R. E.
    Bajrami, I.
    Brough, R.
    Konde, A.
    Campbell, J.
    Rafiq, R.
    Ashworth, A.
    Lord, C. J.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 103 - 104
  • [46] Identifying a Novel Pathogenic Mutation in Exon 3 of ARID1A Gene in Colon Cancer
    Erfani, Mehran
    Mokarram, Pooneh
    Mokhtari, Maral
    Fallahi, Jafar
    MIDDLE EAST JOURNAL OF CANCER, 2020, 11 (02) : 225 - 229
  • [47] RESISTANCE TO PLATINUM-BASED CHEMOTHERAPY IN A MYOEPITHELIAL CARCINOMA WITH A NOVEL ARID1A MUTATION
    Penney, Scott
    Ashcroft, Cody
    Franklin, Nathan
    Whiteway, Susan
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S160 - S161
  • [48] Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer
    Raffone, Antonio
    Travaglino, Antonio
    Saccone, Gabriele
    Cieri, Miriam
    Mascolo, Massimo
    Mollo, Antonio
    Insabato, Luigi
    Zullo, Fulvio
    APMIS, 2019, 127 (09) : 597 - 606
  • [49] Inhibition of HSF1 demonstrates therapeutic efficacy in preclinical models of cholangiocarcinoma
    Carlson, Danielle M.
    Abdelrahman, Amro
    Fogliati, Alessandro
    Lynch, Isaac
    Tomlinson, Jennifer
    Truty, Mark
    Smoot, Rory
    CANCER RESEARCH, 2023, 83 (07)
  • [50] Development of potent antibody drug conjugates against ICAM1+ cancer cells in preclinical models of cholangiocarcinoma
    Zhu, Bing
    Wang, Xinyan
    Shimura, Takaya
    Huang, Andrew C.
    Kong, Nana
    Dai, Yujie
    Fang, Jianmin
    Guo, Peng
    Ying, Jie-Er
    NPJ PRECISION ONCOLOGY, 2023, 7 (01)
12345